Physician-scientist-entrepreneur. Biotech CEO/CSO. Genetics, biotech, birds (mostly raptors), books.

San Mateo, CA
Joined January 2011
Eric Green retweeted
OK, so the $ bio ai assistants are: Ascent Bio - ascentbio.ai/ Bio Protocol BIOS - ai.bio.xyz/ Edison Scientific - edisonscientific.com/ K-Dense - k-dense.ai/ Potato - potato.ai/ SciSpace - scispace.com/biomedical/ Did I miss any?
23
39
2
337
32,255
Eric Green retweeted
We find TDP-43 loss to cause presynaptic defects, which are rescued by ASOs correcting a single cryptic exon in UNC13A. Surprising effect of just one cryptic exon and promising strategy for ALS! Matt Keuss @PeteHarley95 in great collaboration with @jbneuro biorxiv.org/content/10.1101/…
3
29
5
96
13,117
Eric Green retweeted
If there was only one scientific practice I could teach to every scientist regardless of stage or field I think it would be: look at the data. Spot check it. Find a few data points and trace them through to see if they make sense. Look at the raw data. Don't just do analyses.
23
211
51
1,178
215,343
Eric Green retweeted
A variant of APOL1, p.N264K, is associated with reduced risk of CKD and ESKD among carriers of APOL1 high risk variants to levels comparable to individuals with APOL1 low-risk genotypes bit.ly/JASN0219 @DrFlashHeart @MichaelEMatheny @KSusztak @Eddiesiew2 @CassyRCohen
8
28
3,194
A mutation in APOL1 that protects against kidney disease. How does it work? Seems to reduce APOL1 pore function Cool new work integrating human genetics with cellular APOL1 function. 👏@alexbickmdphd @ercgrn @MazeInBiotech journals.lww.com/jasn/fullte…
1
18
1
82
15,205
A 🧵 on some of my intuitions/priors about the genetics of complex and molecular traits in humans (i.e. what I think of as typical), largely motivated by GWAS/QTL studies over the past decade [citing papers with nice figures where possible]
16
242
30
709
269,177
Dr. Stacy Johnson, Dr. Jeffrey Kopp, and Dr. Suzanne Nicholas presented a nice history and overview of APOL1 nephropathy at @GlomCon today. Here are some pearls: 1.) Black patients disproportionately develop CKD + ESKD than other populations.
2
17
45
I hope every single person reads this heartrending profile of a generous and decent couple who loved each other, their son, and their Queens neighbors. I have followed this story, and I am grateful for the reporting by @corinaknoll⁩ ⁦@nytimes⁩ nytimes.com/2022/04/19/nyreg…
24
254
34
843
Eric Green retweeted
Out @Nature! TDP-43 path induces crucial synaptic UNC13A mis-splicing and loss. ALS risk SNPs exacerbate this, worsening disease progression. We uncover the elusive UNC13A risk SNP mechanism, suggesting patients may do better if we correct UNC13A splicing. nature.com/articles/s41586-0…
9
82
7
226
Eric Green retweeted
New paper @Nature! With Pietro Fratta’s team @UCL, we uncovered a link between TDP-43 mis-localization and mis-splicing of UNC13A, a key synaptic gene, in ALS. Exemplifies power of human iPSC neuron models in predicting disease mechanisms + team science. nature.com/articles/s41586-0…
11
49
4
275
Happy to discuss the removal of #race from #eGFR in light of new @ASNKidney @nkf guidelines on this @NEJM @NEJMres360 podcast! It's release is timely given hesitancy to change eGFR reporting and continued denial of the harms of race-based medicine. Check it out and tag a friend!
Clement Lee, MD, MSc@ClementLeeMD13 Jan 2022
Tune in to a rich discussion about race and kidney disease with @AmakaEMD on NEJM Curbside Consults! Was so honored to have her on the podcast. podcasts.apple.com/us/podcas…
4
21
4
81
Eric Green retweeted
FierceBiotech
@FierceBiotech23 Sep 2019
“If you have a disease-causing gene and I have the disease-causing gene, why is it that you may be healthy and I may be sick?” said Maze Therapeutics CEO Jason Coloma. Maze launched out of @ThirdRockV earlier this year. #Fierce15 fiercebiotech.com/special-re…
6
1
12
Eric Green retweeted
Can a Smartwatch Detect HOCM? hcmbeat.com/2019/06/29/can-a… via @HCMBeat
Eric Green retweeted
The diagnosis of hypertrophic cardiomyopathy is often missed. Using a wearable sensor and #AI (ML of PPG) it can be accurately detected nature.com/articles/s41746-0… @Nature_NPJ Digital Medicine by @ercgrn and colleagues #openaccess
1
23
51
This is a big deal and biopharma should be paying much closer attention to it.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
4
12
2
45
Want to learn about how human genetics is impacting development of new medicines Considering this @HMS_ExecEd course in Boston June 4/5 2019: Functional Genomics & Drug Discovery executiveeducation.hms.harva… … 👇🏾 faculty of all-⭐️⭐️ including Andy Plump, head R&D @TakedaPharma
3
6
17